Find Us: 300 London Road, West Croydon, Surrey, CR0 2TG | Pharmacy Enquiries: 0208 684 1352 | OOH Emergency: 0785 2245 952
Mounjaro (tirzepatide) has gained significant attention as a powerful new weight loss medication, offering promising results for individuals struggling with obesity. However, many people searching for Mounjaro NHS prescriptions are disappointed to find that it is not yet widely available for weight management. Currently, the NHS primarily prescribes Mounjaro only for patients with type 2 diabetes who have a high BMI.
At Shivas Pharmacy, we understand the frustration of those seeking effective weight loss treatments and want to provide clear information about why Mounjaro is not yet available on the NHS for weight loss, the regulatory approval process, and how you can access it privately.
The NHS follows strict guidelines when approving medications for specific conditions, particularly when it comes to weight loss treatments. While Mounjaro has been approved for use in the UK, it is currently only prescribed on the NHS for managing type 2 diabetes in patients with a high BMI. This is because its initial approval came as a treatment for diabetes, rather than for general weight management.
For a drug to be widely available on the NHS for a different condition, it must go through a separate approval process by the National Institute for Health and Care Excellence (NICE), which evaluates its effectiveness, safety, and cost-efficiency.
Currently, Mounjaro is under review for weight loss treatment, but until this process is complete, the NHS will not routinely prescribe it for weight management alone.

Before a medication can be offered as an NHS-funded weight loss treatment, it must go through several key steps:
MHRA Approval – The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) must first approve the drug as safe and effective for its intended use. Mounjaro has already passed this stage for diabetes treatment.
NICE Review – NICE assesses whether the drug is cost-effective and beneficial for the NHS to prescribe for non-diabetic obesity patients. This involves clinical trials, real-world data analysis, and cost-benefit comparisons with existing NHS weight loss treatments.
NHS Funding and Rollout – If NICE recommends Mounjaro for weight loss, the NHS then determines how to integrate it into weight management services and whether it will be available for free or require partial payment.
The approval process for weight loss treatments can take time. Wegovy (semaglutide), another weight loss injection, was approved by NICE in early 2023, but NHS availability has been gradual and limited. Mounjaro is expected to follow a similar path, meaning it could be at least 2025 before it becomes widely available on the NHS for weight loss.
Additionally, even if NICE approves Mounjaro for NHS-funded weight loss treatment, availability may be restricted to specific groups, such as individuals with a BMI over 35 or those with obesity-related health conditions.
Yes, Mounjaro is available through private prescriptions, making it an option for those who want access before the NHS approves it for weight management. Many people opt for private treatment because it provides:
Faster access – No need to wait for NHS approval or availability.
More flexibility – Can be prescribed based on clinical need rather than strict NHS criteria.
Personalised support – Private clinics and pharmacies offer tailored weight loss plans alongside medication.
At Shivas Pharmacy, we offer private consultations for a range of weight loss treatments, including Mounjaro and Wegovy, allowing you to find the most suitable option for your weight loss journey.

While Mounjaro is not yet available for weight loss through the NHS, other options do exist, including:
Wegovy (semaglutide) – Approved for NHS use but currently in limited supply. Works similarly to Mounjaro by reducing appetite and food intake.
Orlistat (Xenical) – A medication that blocks fat absorption but is less effective than newer weight loss injections.
NHS Weight Management Programmes – Includes lifestyle coaching, exercise support, and referrals for weight loss surgery in extreme cases.
For now, Mounjaro NHS prescriptions remain limited to diabetes management. While its approval for weight loss treatment is expected, the process could take another year or more. In the meantime, private prescriptions offer an alternative for those who wish to begin treatment sooner.
If you are considering Mounjaro for weight loss, Shivas Pharmacy provides expert consultations and private prescriptions, ensuring safe and professional access to this groundbreaking treatment. Contact us today to find out more about your options and start your weight loss journey with the right medical support.

This blog was written on behalf of Shivas Pharmacy by Pharmacy Mentor.